loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for 1-(Perfluorohexyl)Octane

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    1-(Perfluorohexyl)Octane

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bausch+Lomb: New Data On Consumer, Vision, Pharma Products At Optometry Meet
    Bausch+Lomb: New Data On Consumer, Vision, Pharma Products At Optometry Meet

    28 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240528246464/en

    BUSINESSWIRE
    28 May 2024
    Share Share
    Bausch + Lomb Launches MIEBO in the United States
    Bausch + Lomb Launches MIEBO in the United States

    12 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230912964741/en

    BUSINESSWIRE
    12 Sep 2023
    Share Share
    Senju Pharmaceutical and Novaliq Enter Into License Agreement For NOV03
    Senju Pharmaceutical and Novaliq Enter Into License Agreement For NOV03

    13 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230612304814/en

    BUSINESSWIRE
    13 Jun 2023
    Share Share
    Bausch + Lomb and Novaliq win approval for dry eye disease treatment
    Bausch + Lomb and Novaliq win approval for dry eye disease treatment

    19 May 2023

    // Nicole DeFeudis ENDPTS

    https://endpts.com/bausch-lomb-and-novaliq-win-approval-for-dry-eye-disease-treatment/

    Nicole DeFeudis ENDPTS
    19 May 2023
    Share Share
    Bausch + Lomb & Novaliq Announce Publication of Phase 3 Data on NOV03
    Bausch + Lomb & Novaliq Announce Publication of Phase 3 Data on NOV03

    22 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230322005260/en

    BUSINESSWIRE
    22 Mar 2023
    Share Share
    Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03
    Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03

    04 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230104005244/en

    BUSINESSWIRE
    04 Jan 2023
    Share Share